One-carbon Metabolism and Epigenetic Elements are Modulated by miR-1914-5p in an in Vitro Model of Steatosis
- PMID: 40911170
- DOI: 10.1007/s12013-025-01881-5
One-carbon Metabolism and Epigenetic Elements are Modulated by miR-1914-5p in an in Vitro Model of Steatosis
Keywords: Antioxidant cellular machinery; DNA and histone methylation; fatty liver; hepatic co-culture; microRNA; once-carbon metabolism.
Conflict of interest statement
Declarations. Conflict of interest: The authors have declared that no competing interests.
Similar articles
-
Elevated miR-34a induced by lipotoxicity and inflammation mediates pathophysiological communication between hepatocytes and hepatic stellate cells in liver fibrosis.Genes Dis. 2025 Apr 18;12(6):101648. doi: 10.1016/j.gendis.2025.101648. eCollection 2025 Nov. Genes Dis. 2025. PMID: 40837409 Free PMC article.
-
Multi-Cohort Exploration of Repetitive Element Transcription and DNA Methylation in Human Steatotic Liver Disease.Int J Mol Sci. 2025 Jun 8;26(12):5494. doi: 10.3390/ijms26125494. Int J Mol Sci. 2025. PMID: 40564961 Free PMC article.
-
Mesenchymal stem cell-derived lncRNAs NKILA contributes to stemness and chemoresistance by fatty acid oxidation in gastric cancer via miR-485-5p/STAT3.World J Gastrointest Oncol. 2025 Aug 15;17(8):105006. doi: 10.4251/wjgo.v17.i8.105006. World J Gastrointest Oncol. 2025. PMID: 40837764 Free PMC article.
-
[Epigenetics' implication in autism spectrum disorders: A review].Encephale. 2017 Aug;43(4):374-381. doi: 10.1016/j.encep.2016.07.007. Epub 2016 Sep 28. Encephale. 2017. PMID: 27692350 French.
-
MASLD: insights on the role of folate in hepatic lipid metabolism.Front Nutr. 2025 Jul 16;12:1583674. doi: 10.3389/fnut.2025.1583674. eCollection 2025. Front Nutr. 2025. PMID: 40740648 Free PMC article. Review.
References
-
- Teng, M. L., Ng, C. H., Huang, D. Q., et al. (2023). Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology, 29, S32–S42. https://doi.org/10.3350/cmh.2022.0365 - DOI - PubMed
-
- Younossi, Z. M., & Henry, L. (2024). Understanding the burden of nonalcoholic fatty liver disease: Time for action. Diabetes Spectrum, 37, 9–19. https://doi.org/10.2337/dsi23-0010 - DOI - PubMed - PMC
-
- Younossi, Z. M. (2019). Non-alcoholic fatty liver disease – a global public health perspective. Journal of Hepatology, 70, 531–544. https://doi.org/10.1016/j.jhep.2018.10.033 - DOI - PubMed
-
- Song, Y., Chen, B., Jiang, L., et al. (2024). Global trends of treatment for NAFLD from 2012 to 2021: A bibliometric and mapping analysis. Endocrine, Metabolic & Immune Disorders: Drug Targets, 24, 573–584. https://doi.org/10.2174/0118715303230418230925060312 - DOI
-
- Younossi, Z. M., Koenig, A. B., Abdelatif, D., et al. (2016). Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64, 73–84. https://doi.org/10.1002/hep.28431 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources